ARTICLE | Clinical News
CEP-1347: Started Phase II-II
August 5, 2002 7:00 AM UTC
Cephalon Inc. (CEPH),West Chester, Penn. H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Product: CEP-1347 Business: Neurological Therapeutic category: Neuroprotectant Target: Kinases Description: Mix...